AJ

Antima Jain

Active Director Director DIN 10527625
DIN 10527625 First appointment Feb 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Antima Jain

Data last updated:

Antima Jain is a Director at Krenko Technologies Private Limited (since 2024). The company operates in Healthcare.

DIN 10527625
Primary Designation Director
Industry Healthcare
First Appointment 28 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Krenko Technologies Private Limited U63991HR2024PTC119363
Director28 Feb 20242024Active

Board colleagues of Antima Jain

NameDINCompanyDesignation
Amreesh Kumar Jain11029885Krenko Technologies Private LimitedAdditional Director
Rajni Bansal00073162Krenko Technologies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Krenko Technologies Private Limited
Premium access

Shareholding and investment profile for Antima Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Antima Jain

Antima Jain currently holds 1 directorship: Krenko Technologies Private Limited (Director, since 28 Feb 2024).

Antima Jain was first appointed on 28 Feb 2024 as Director at Krenko Technologies Private Limited.

The current boards of Antima Jain's companies include Amreesh Kumar Jain (Krenko Technologies Private Limited), Rajni Bansal (Krenko Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available